Cargando…
Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients
INTRODUCTION: Autologous hematopoietic stem cell transplantation (ASCT) is a well-established treatment for patients with multiple myeloma (MM), and adequate stem cell collection must be assured before ASCT. However, prediction of poor mobilizers (PMs) is still difficult despite several risk factors...
Autores principales: | Hsu, Te-Lin, Tsai, Chun-Kuang, Liu, Chun-Yu, Yeh, Chiu-Mei, Lin, Fen-Lan, Hsiao, Liang-Tsai, Liu, Yao-Chung, Wang, Hao-Yuan, Ko, Po-Shen, Lin, Ting-An, Chen, Wen-Chun, Chen, Po-Min, Liu, Jin-Hwang, Gau, Jyh-Pyng, Liu, Chia-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912005/ https://www.ncbi.nlm.nih.gov/pubmed/36818774 http://dx.doi.org/10.1159/000525565 |
Ejemplares similares
-
Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
por: Lin, Wen‐Ying, et al.
Publicado: (2022) -
The influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation
por: Tsai, Chun-Kuang, et al.
Publicado: (2021) -
A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma
por: Liu, Chia‐Jen, et al.
Publicado: (2020) -
The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020) -
Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
por: Hsu, Pei, et al.
Publicado: (2015)